GeneralConnection.com ➔ Dictionary
Dictionary Search

psoriasis

Synonyms

Noun

1. skin disease

2. disease of the skin, skin disorder, skin problem, skin condition

Usage
How Well-Being in Psoriasis is Being Assessed Via WHO-5, With Ulrich Mrowietz, MD - HCPLive
Skip the Stairs: The Elevator Approach to Psoriasis - Medscape
First-in-Class Oral Piclidenoson Reaches Pivotal Phase 3 Enrollment Milestone in Plaque Psoriasis - Dermatology Times
Milestone Alert: Can-Fite Completes Enrollment in Phase 3 Trial of Oral Piclidenoson for Psoriasis - The Dermatology Digest
Intelligent Psoriasis Research Suggests New Care Model - European Medical Journal
Can-Fite Achieves Key Pivotal Phase 3 Psoriasis Milestone with Completion of Patient Enrolment for the Interim Analysis: Data Expected Q4 2026/Q1 2027 - markets.businessinsider.com
Can-Fite’s psoriasis study reaches interim analysis after 247 patients enrolled - Stock Titan
FDA Approves Risankizumab for Pediatric Plaque Psoriasis, Psoriatic Arthritis - Pharmacy Times – Pharmacy Practice News and Expert Insights
Fosun pays $32M to join Lilly and Novartis in psoriasis market - Fierce Biotech
FDA Expands Zoryve Cream 0.3% Approval for Plaque Psoriasis Down to Age 2 - MPR - Medical Professionals Reference
The #1 Nutrient to Focus On to Reduce Your Risk of Psoriasis - EatingWell
National Psoriasis Foundation Releases Guidance on GLP-1 RA Use - Dermatology Advisor
Bidirectional phenotype switching between psoriasis and atopic dermatitis characterised - Hospital Healthcare Europe
Are High Dose, Extended Half-Life IL-23 Inhibitors the Next Big Step in Psoriasis Care? - Docwire News
Psoriasis as a systemic inflammatory disease: an immune set-point framework for comorbidities and relapse - Frontiers
8 Dermatology Headlines You Missed in June 2026 - HCPLive
Can-Fite (NYSE American: CANF) reaches key Phase 3 psoriasis interim analysis milestone - Stock Titan
Skyrizi Earns FDA Pediatric Approval for Psoriatic Disease in Patients Aged 6+ - MPR - Medical Professionals Reference
Topical Roflumilast Approved for Psoriasis Down to Age 2 - Medscape
FDA Approves Risankizumab for Children With Psoriasis, PsA - Medscape
FDA Expands Risankizumab Approval to Pediatric Plaque Psoriasis, Active PsA - AJMC
Transcriptomic profiling and machine learning uncover gene signatures of psoriasis endotypes and disease severity - Nature
Foods to Avoid With Psoriasis: What to Eat, Triggers to Avoid - Verywell Health
FDA Approves Roflumilast Cream 0.3% for Plaque Psoriasis Down to Age 2 - Dermatology Times
Marine oil fatty acid shows promise against psoriasis in lab study - Global Seafood Alliance
Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis - NEJM Evidence
Skin-derived myeloid precursors and joint-resident fibroblasts spread psoriatic disease from skin to joints - Nature
Psoriasis-like disease prevents squamous skin tumor development by neutrophil-driven inflammation - PNAS
Immunogenetics in psoriasis: towards personalised diagnosis and treatment strategies - Nature
Pediatric Plaque Psoriasis Treatment Set to Expand in Europe - Medscape
Journal of the European Academy of Dermatology and Venereology - Wiley Online Library
Proactive Treatment Strategies for Scalp Psoriasis - Medscape
Advancements in psoriasis classification using custom transfer learning algorithms - Nature
Biologics Continue to Revolutionize Psoriasis Care - Medscape
Takeda's AI-crafted psoriasis pill tops Bristol Myers' Sotyktu in head-to-head trial - Reuters
GLP-1 Drug Makes Its Case for Treating Plaque Psoriasis - MedPage Today
Fatty acid-binding protein 5 aggravates psoriasis and psoriasis-like disease through ferroptosis - Nature
FDA Approves Icotrokinra, First Oral IL-23 Inhibitor for Plaque Psoriasis - AJMC
GLP-1 Drugs Tackle Both Skin Inflammation and Metabolism in Psoriasis - AJMC
Tackling Psoriasis and Overweight/Obesity Together - Docwire News
Comparative Effectiveness of Four Biologics for Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis - Cureus
Macrophages Gain Attention as Psoriasis Research Evolves - AJMC
Are Essential Oils Helpful For Psoriasis? - Verywell Health
Risankizumab outperforms deucravacitinib in moderate psoriasis, interim trial data show - Hospital Healthcare Europe
A randomized phase 2 clinical trial to treat moderate-to-severe plaque psoriasis patients with high-induction dosing of risankizumab - Nature
As Stelara fades, J&J touts early momentum for new psoriasis pill Icotyde - FirstWord Pharma
FDA Approves Roflumilast Cream for Children as Young as 2 With Plaque Psoriasis - Dermatology Times
The complex interplay between psoriasis and depression: from molecular mechanisms to holistic treatment approaches - Frontiers
The Future of Psoriasis Management: Integration, Innovation, and Holistic Care - AJMC
IL-23 Inhibitors Linked to Lower PsA Risk in Psoriasis Study - Medscape
9 Health Conditions Linked to Psoriasis - Everyday Health
Takeda’s TYK2 inhibitor beats Bristol Myers’ Sotyktu in phase 3 psoriasis showdown - Fierce Biotech
Chronic Plaque Psoriasis With Persistent Facial Involvement Successfully Treated With Risankizumab: A Case Report - Cureus
Upadacitinib is effective in treating psoriasis combined with lichen planus: a case report - Frontiers
Severe Psoriasis Flare Care: Dermatologist Tips - HealthCentral
Can-Fite BioPharma (CANF) Completes Patient Enrollment for Psori - GuruFocus
Acute erythrodermic psoriasis complicated by systemic capillary leak syndrome following secukinumab therapy: a case report - Frontiers
FDA Approves Oral Icotrokinra for Moderate to Severe Plaque Psoriasis - Rheumatology Advisor
New French Psoriasis Guidelines Add Biologics, Comorbidity Guidance to Algorithm - AJMC
Red Light Therapy for Psoriasis: Effectiveness, Safety, How to Use - Healthgrades
Investigating the Use of GLP-1 Receptor Agonists in Psoriasis and Hidradenitis Suppurativa - Dermatology Times
Unusual Presentation of Pustular Psoriasis on the Face: A Case Report - Cureus
Emerging Oral Therapies Set to Transform the Psoriasis, PsA Treatment Landscape: Linda Stein Gold, MD - AJMC
The co-impact of diabetes and psoriasis on mortality risk for all causes and specific causes - Nature
Analyzing IL-23 Inhibitors in Psoriasis - HCPLive
Takeda’s Zasocitinib Significantly Outperforms Deucravacitinib in Head-to-Head Phase 3 Psoriasis Study, Promising to Redefine Oral Treatment Expectations - Business Wire
Dual-Site Inflammation During Adalimumab Therapy: Birdshot Chorioretinopathy Complicated by Paradoxical Psoriasis - Cureus
NMI promotes the secretion of IL-17 and exacerbates psoriasis - PNAS
Shared inflammatory architecture and therapeutic tensions between psoriasis and Crohn’s disease - Frontiers
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025 - Dermatology Times
Unseen Delays: How Psoriasis Disrupts the Wound Healing Landscape - Dermatology Times
Severe Psoriasis: Causes, Symptoms, and What’s Happening - HealthCentral
Zasocitinib Hits Phase 3 End Points in Plaque Psoriasis - AJMC
How To Tell if You Have Psoriasis on the Scalp - Health: Trusted and Empathetic Health and Wellness Information
Roflumilast Cream Expands Pediatric Plaque Psoriasis Care, With Jennifer Soung, MD - HCPLive
Supplements for Psoriasis: What Are Their Benefits and Risks? - Verywell Health
Targeted Oral Peptide Icotrokinra for Psoriasis Involving High-Impact Sites - NEJM Evidence
The Psoriasis Pipeline Heats Up: What Clinicians Need to Know - Dermatology Times
Mediterranean Diet May Ease Psoriasis Symptoms - HealthCentral
J&J wins approval for first-of-its-kind psoriasis pill - STAT
Pustular psoriasis flare following COVID-19 infection: a case report and literature review - Frontiers
Do Supplements Help Psoriasis? What the Research Shows - HealthCentral
Lilly's Zepbound and Taltz improve psoriasis symptoms, drive weight loss in study - CNBC
Phase 3 Results Signal a New Era for Oral Targeted Therapy in Psoriasis - Dermatology Times
Environmental toxicant ochratoxin A induces psoriasis based on network toxicology machine learning and molecular docking analyses - Nature
Combined Diagnostic Approach Improves Accuracy in Differentiating Eczema From Psoriasis - AJMC
Scientists discover hidden sugar layer behind psoriasis - ScienceDaily
The Surprising Link Between Psoriasis and High Blood Pressure - Everyday Health
Psoriasis and Skin Infections: Risks, Common Types, and Prevention Tips - Everyday Health
Icotrokinra Data at Maui Derm 2026 Reaffirm Efficacy in Psoriasis - HCPLive
Treatment Options for Plaque Psoriasis You Should Know - Health: Trusted and Empathetic Health and Wellness Information
Epigenetic and Transcriptional Regulatory Networks Underlying Psoriasis Pathogenesis - ScienceDirect.com
FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi - CNBC
Advancements in psoriatic arthritis research and care - Nav - Bristol Myers Squibb
FDA Approves Icotrokinra for Moderate-to-Severe Plaque Psoriasis - Medscape
Once-Daily Oral Zasocitinib Delivers Rapid, Durable Skin Clearance for Psoriasis: Melinda Gooderham, MD, MSc, FRCPC - AJMC
A Win for Patients and Providers: Roflumilast’s Expanded PsO Indication - Dermatology Times
4 Best Foods for Psoriasis, According to Nutrition Experts - EatingWell
GPP flare? Know when to get urgent care - Cleveland Clinic Health Essentials
Ensuring Patients with Severe Psoriasis Get the Medication They Need - University of Miami
Foreign Language Equivalents
Foreign Language Equivalents of 'psoriasis'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
psoriasiss,   psoroasis,   psoriaais,   psoirasis,   posriasis,   psoriadis,   psoriasiis,   psotiasis,   pspriasis,   [soriasis,   psiriasis,   sporiasis,   psoraisis,   osoriasis,   psoruasis,   soriasis,   psooriasis,   poriasis,   pssoriasis,   psoriasos,   psoriaasis,   psoriass,   psorasis,   psoriassi,   psoriiasis,   psoriaiss,   psriasis,   psoriasus,   psoriais,   psoriasia,   psoriasi,   psoriassis,   pdoriasis,   psroiasis,   psorisis,   psoiasis,   psorissis,   ppsoriasis,   psoeiasis,   psorriasis,   paoriasis,   psoriasid,   pseriasis,   psorisais
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z